SUNITINIB AS FIRST-LINE TREATMENT FOR METASTATIC RENAL CELL CARCINOMA (MRCC): UPDATED RESULTS AND ANALYSIS OF PROGNOSTIC FACTORS FROM A PHASE III RANDOMISED TRIAL
Oudard, S, Motzer, R.J, Michaelson, M.D, Hutson, T.E, Tomczak, P, Bukowski, R.M, Rixie, O, Negrier, S, Kim, S.T, Chen, I, Figlin, R.A
Published in European urology supplements : official journal of the European Association of Urology (2008)
Published in European urology supplements : official journal of the European Association of Urology (2008)
Get full text
Journal Article